15.34

15.34 (0.13%)

As of Feb 23, 2024

Celcuity Inc. [CELC]

Source: 

Company Overview

Celcuity Inc is a clinical-stage biotechnology company focused on development of targeted therapies for treatment of multiple solid tumor indications. Our lead therapeutic candidate is gedatolisib, a pan-PI3K/mTOR inhibitor.

CountryUS
Headquartersminneapolisminnesota
Phone Number(763) 392-0767
Industryservices-medical laboratories
CEOBrian F. Sullivan
Websitecelcuity.com